SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
WARRELL RAYMOND P JR

(Last) (First) (Middle)
C/O GENTA INCORPORATED
200 CONNELL DRIVE

(Street)
BERKELEY HEIGHTS NJ 07922

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
GENTA INC DE/ [ GETA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chairman & CEO
3. Date of Earliest Transaction (Month/Day/Year)
11/30/2009
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/30/2009 A 916,431 A (1) 45,703,622(2) D
Common Stock 11/30/2009 A 104,676 A (3) 45,808,298 D
Common Stock 11/30/2009 S 600,000 D $0.145 45,208,298 D
Common Stock 12/01/2009 S 1,000 D $0.144 45,207,298 D
Common Stock 12/02/2009 S 1,179,000 D $0.139 44,028,298 D
Common Stock 11,749,034(4) I Spouse
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Vesting of restricted stock units previously reported.
2. Includes 2,077,759 shares of common stock held in the reporting person's IRA, 4,414,585 shares of common stock held in a joint account with the reporting person's spouse,Dr. Itri, 17,624,232 shares of common stock underlying the Senior Secured Convertible Promissory Notes due June 9, 2010 (the "Notes") and 21,587,046 shares of common stock underlying restricted stock units that have not vested as of the reporting date.
3. Vesting of restricted stock units by the reporting person's spouse, Dr. Itri, previously reported.
4. Includes 3,114,224 shares of common stock held in the reporting person's spouse, Dr. Itri's IRA of which the reporting person is the beneficiary, 121,096 shares of common stock issuable upon the conversion of the Notes by Dr. Itri and 8,513,714 shares of common stock underlying restricted stock units that have not vested as of the reporting date.
Remarks:
The sales reported on this Form 4 were undertaken to cover tax liabilities to the reporting person and his spouse, Dr. Itri, exceeding $740,000 for the vesting of approximately 5.4 million shares of restricted stock units on August 31, 2009 and November 30, 2009 at prices of $0.38 per share and $0.149 per share, respectively. The transactions reported on this Form 4 comprise less than 4% of Genta securities held by Drs. Warrell and Itri.
/s/Raymond P. Warrell, Jr. 12/03/2009
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.